A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma
Enrolling by invitation
Conditions studied: Open-Angle Glaucoma
In brief
The goal of this study is to learn about outcomes after bio-reinforced canaloplasty surgery in patients with OAG. The key question the study aims to answer is: How much does the surgical procedure lower pressure inside the eye and what is the durability of this effect? Participants will return for periodic eye exams for 2 years following surgery.
Key facts
- Study ID
- NCT07520175
- Run by
- Iantrek, Inc.
- People needed
- 300
- Starts
- 2026-04-01
- Expected to finish
- 2029-12-01
- Last updated by the study team
- 2026-07-22
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of OAG in the study eye and a candidate for bio-reinforced canaloplasty for aqueous outflow enhancement, as determined by investigator
You may not qualify if…
- Diagnosis of acute angle closure, traumatic, congenital, malignant, uveitic, or neovascular glaucoma in the study eye 2. Previous minimally invasive or filtering glaucoma surgery in the study eye 3. Previous IOP-lowering procedure ≤ 12 weeks prior to bio-reinforced canaloplasty in the study eye 5. Previous investigational, or non-standard of care procedures and/or treatments ≤ 12 weeks prior to bio-reinforced canaloplasty
Where it is running
- North Valley Eye Care — Chico, California, United States
- North Bay Eye Associates — Petaluma, California, United States
- Twin Cities Eye Consultants — Coon Rapids, Minnesota, United States
- Cataract & Laser Institute — Medford, Oregon, United States
- Scott & Christie Eyecare Associates — Cranberry Township, Pennsylvania, United States
- Key-Whitman Eye Center — Dallas, Texas, United States
- El Paso Eye Surgeons — El Paso, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.